SANTA ANA, CA--(Marketwired - Mar 19, 2014) - BioLargo, Inc. (
Dennis Calvert, BioLargo's president, stated: "The NSN assignment is a significant milestone as it establishes an important sales channel for these products, as well as provides a pathway for introducing additional products. NSNs are officially recognized by the United States government, the North Atlantic Treaty Organization (NATO) and many governments around the world. In addition, NSNs are assigned for products frequently reordered by the military and other agencies, representing a significant long-term market opportunity for BioLargo. This sales channel is particularly well suited for our advanced wound care products in development by our subsidiary Clyra Medical Technologies. Due to the potential of this market and our multiple product applications within the military channel, we have established a small working capital line of credit to complement our cash on hand to support our increased sales efforts."
The company's body fluid solidifiers are used to solidify bodily fluids evacuated during surgery, in hospital settings and military deployment situations. Using BioLargo's advanced iodine technology, the products provide advanced holding power, increased safety, and superior odor control in an easy to use mechanism that requires no special handling.
"Our products went through a comprehensive evaluation process by healthcare providers in multiple Military Medical Facilities (MMFs), after which the product received positive reviews and was suggested for NSN assignment by the U.S. Army. This validation reflects the traction we expect these products will gain in markets outside the military channel as well," concluded Calvert.
Downeast Logistics, a certified Service-Disabled Veteran-Owned Small Business (SDVOSB) with 13 years in operations, helped organize this sales channel and also supports BioLargo as a distribution partner to facilitate its expanding sales initiatives within its Odor-No-More subsidiary. Downeast Logistics' designation as a SDVOSB places it within a group of highly sought after vendors to the US government.
About BioLargo, Inc.
BioLargo, Inc. (
Safe Harbor Statement
The statements contained herein, which are not historical, are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements, including, but not limited to, the risks and uncertainties included in BioLargo's current and future filings with the Securities and Exchange Commission, including those set forth in BioLargo's Annual Report on Form 10-K for the year ended December 31, 2012.
Becky Herrick and Kirsten Chapman